Illumina Signs Agreement to Acquire GenoLogics

San Diego, CA — Illumina, Inc. (NASDAQ: ILMN) today announced it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations.… Continue reading